Physical and biological dosimetry in patients undergoing radiosynoviorthesis with erbium-169 and rhenium-186

Nuclear Medicine Communications

Volumn 22, Issue 4, 2001, Pages 405-416

  Manil, L ^a   Voisin, P ^a   Aubert, B ^a   Guerreau, D ^a   Verrier, P ^a   LebEgue L ^a   Wargnies, J P ^a   Di Paola, M ^a   Barbier, Y ^a   Chossat, F ^a   Menkes, C J ^a   TEBIB J ^a   Devaux, J Y ^a   Kahan, A ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Biological dosimetry; Erbium 169; Physical dosimetry; Radiosynoviorthesis; Rhenium 186; Rheumatoid arthritis

Indexed keywords

ERBIUM 169; RHENIUM 186;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DOSIMETRY; ELECTRON THERAPY; FEMALE; GAMMA IRRADIATION; HUMAN; INJECTION; JOINT; LYMPHOCYTE; MALE; RADIATION DOSE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SYNOVIORTHESIS; WHOLE BODY SCINTISCANNING;

ADULT; ARTHRITIS, RHEUMATOID; BETA RAYS; CHLORIDES; DATA INTERPRETATION, STATISTICAL; ERBIUM; GAMMA RAYS; HUMANS; INJECTIONS, INTRA-ARTICULAR; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RHENIUM; TISSUE DISTRIBUTION;

EID: 0035074717     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200104000-00009     Document Type: Article

References (26)

1. Clunie G, Lovegrove FT. Radiation synovectomy. In: Murray IPC, Ell PJ, eds. Nuclear medicine in clinical diagnosis and treatment. Edinburgh: Churchill Livingstone, 1998.
2. Oka H, Hyphen M. Radiation synovectomy: results in rheumatoid knee effusions treated with radioactive yttrium. Scand J Rheumatol 1974; 3: 33-38.
3. Johnson LS, Yanch JC, Shortkroft S, Barnes CL, Spitzer AI, Sledge CB. Beta-particle dosimetry in radiation synovectomy. Eur J Nucl Med 1995; 22: 977-988.
4. Ruotsi A, Hypen M, Rekonen A, Oka M. Erbium-169 versus triamcinolone hexacetonide in the treatment of rheumatoid finger joints. Ann Rheum Dis 1979; 38: 45-47.
5. Delbarre F, Menkes CJ, Aignan M, Roucayrol JC, Ingrand J, Sanchez A. Une nouvelle préparation radioactive pour la synoviorthèse; le rhénium-186 colloïdal. Nouv Presse Méd 1973; 20: 1372.
6. Sanchez CA. Estudio sobre la migracion de un coloide de Rhenio 186 despues de inyeccion intra-articular. Rhumatologie (Paris) 1975; 5: 671-677.
7. Houvenagel E, Deboury L, Leloire O, et al. Anomalies cytogénétiques après synoviorthèse isotopique au cours de la polyarthrite rhumatoïde. Rev Rhumatisme 1991; 58: 31-34.
8. Gratz S, Göbel D, Behr TM, et al. Radiosynoviorthesis with Re-186-sulphate, Er-169-citrate and Y-90-citrate for radiation synovectomy: first dosimetric data. Eur J Nucl Med 1997; 24/8: 927
9. Deutsch E, Brodack JW, Deutsch KF. Radiation synovectomy revisited. Eur J Nucl Med 1993; 20: 1113-1127.
10. International Commission on Radiation Units and Measurements (ICRU). Methods of assessment of absorbed dose in clinical use of radionuclides, Report no. 32. Town: ICRU, 1979.
11. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid polyarthritis. Arthr Rheum 1987; 31: 315-324.
12. Voisin P, Lloyd D, Edwards A. Chromosome aberrations scoring for biological dosimetry in a criticality accident. Radiat Prot Dosim 1997; 70: 467-470.
13. International Atomic Energy Agency (IAEA). Biological dosimetry. Chromosomal aberration analysis to dose assessment. Technical reports, series no. 260. Wien: IAEA, 1986.
14. International Commission on Radiological Protection (ICRP). Recommendations of the International Commission on Radiological Protection. Report 60, 1990. Annals ICRP 1991; 21 (1-3).
15. International Commission on Radiological Protection (ICRP). Report of the Task Group on Reference Man. Publication 23. Oxford: Pergamon, 1975.
16. Harbert JC. Nuclear medicine therapy. New York: Thieme Medical, 1987.
17. Stabin MG. MIRDOSE (3): personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996; 37: 538-546.
18. Schlaghecke R, Beuscher D, Kornely E, Specker C. Effects of glucocorticoids in rheumatoid arthritis. Diminished glucocorticoid receptors do not result in gluocorticoid resistance. Arthr Rheum 1994; 37: 1127-1131.
19. van den Brink HR, van Wijk MJ, Bijlsma JW. Influence of steroid hormones on proliferation of peripheral blood mononuclear cells in patients with rheumatoid arthritis. Br J Haematol 1992; 31: 663-667.
20. Wascher TC, Hermann J, Brezinshek HP, et al. Cell-type specific response of peripheral blood lymphocytes to methotrexate in the treatment of rheumatoid arthritis. Clin Invest 1994; 72: 535-540.
21. Lacki JK, Schochat T, Sobieska M, et al. Immunological studies in patients with rheumatoid arthritis treated with methotrexate or cyclophosphamide. Z Rheumatol 1994; 53: 76-82.
22. Verwilghen J, Kingsley GH, Gambling L, Panayi GS. Activation of gold-reactive T lymphocytes in rheumatoid arthritis patients treated with gold. Arthr Rheum 1992; 35: 1413-1418.
23. Venkatachalam P, Paul SFD, Mohankumar MN, et al. Higher frequency of dicentrics and micronuclei in peripheral blood lymphocytes of cancer patients. Mutat Res 1999; 425: 1-8.
24. Lloyd DC, Reeder EJ. Chromosome aberrations and intra-articular yttrium-90. Lancet 1978; March 18: 617.
25. International Commission on Radiological Protection (ICRP). Radiation dose to patients from radiopharmaceuticals. Publication 53. Annals ICRP 1987; 18 (1-4).
26. Göbel D, Gratz S, von Rothkirch T, Becker W, Willert HG. Radiosynoviorthesis with rhenium-186 in rheumatoid arthritis: a prospective study of three treatment regimens. Rheumatol Int 1997; 17: 105-108.